Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PORFIMER for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where PORFIMER was used for Lung neoplasm malignant.

Most Reported Side Effects for PORFIMER

Side Effect Reports % Deaths Hosp.
Off label use 15 11.3% 3 1
Dyspnoea 13 9.8% 3 10
Oesophageal stenosis 13 9.8% 1 1
Cholangitis 12 9.0% 0 9
Hypotension 9 6.8% 2 9
Nausea 8 6.0% 2 8
Oedema peripheral 8 6.0% 2 8
Photosensitivity reaction 8 6.0% 0 2
Pyrexia 8 6.0% 3 8
Swelling face 8 6.0% 0 5
Atrial fibrillation 7 5.3% 1 5
Pneumonia 7 5.3% 2 6
Pulmonary air leakage 7 5.3% 0 7
Sepsis 7 5.3% 3 6
Erythema 6 4.5% 1 1

Other Indications for PORFIMER

Product used for unknown indication (21) Cholangiocarcinoma (12) Oesophageal squamous cell carcinoma (12) Oesophageal carcinoma (9) Barrett's oesophagus (8) Pleural mesothelioma malignant (8) Brain neoplasm (5) Obstructive airways disorder (5) Squamous cell carcinoma (5)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

PORFIMER Full Profile All Lung neoplasm malignant Drugs PORFIMER Demographics PORFIMER Timeline